Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
LHLabcorp
FinDog View：Bullish
| Metric | CVS | LH |
|---|
| Close | 90.25 | 361.39 |
| Market Cap | $116B | $29.3B |
| 1M | +5.32% | +17.29% |
| P/E (TTM) | 23.8 | 29.9 |
| Forward P/E | 10.4 | 16.0 |
| P/E 5-Yr Percentile | 65 | 58 |
| P/S | 0.3 | 2.1 |
| P/B | 1.5 | 3.5 |
| Dividend Yield | 3.49% | 1.35% |
| Latest Quarter Revenue | $106B | $3.8B |
| Revenue YoY | +7.3% | +6.9% |
| Gross Margin | 44.5% | 29.1% |
| Latest Quarter EPS | 2.31 | 3.22 |
| Avg Post-Earnings Move | ±2.3% | ±1.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.94% | 3.12% |
| 90-Day Net Insider Buying | — | −$3.2M |
CVS · Revenue, Last 8 Quarters ($B)
LH · Revenue, Last 8 Quarters ($B)
